Chloramphenicol/hydrocortisone/polymyxin b ophthalmic Interactions
There are 294 drugs known to interact with chloramphenicol/hydrocortisone/polymyxin b ophthalmic, along with 3 disease interactions. Of the total drug interactions, 1 is major, and 293 are moderate.
Medications known to interact with chloramphenicol/hydrocortisone/polymyxin b ophthalmic
Note: Showing generic names only.
- abacavir
- abemaciclib
- abrocitinib
- acalabrutinib
- adagrasib
- adalimumab
- ado-trastuzumab emtansine
- afamitresgene autoleucel
- albendazole
- aldesleukin
- alemtuzumab
- altretamine
- amprenavir
- anti-thymocyte globulin (rabbit)
- aripiprazole
- asciminib
- asparaginase escherichia coli
- atazanavir
- auranofin
- aurothioglucose
- axicabtagene ciloleucel
- azacitidine
- azathioprine
- baricitinib
- belantamab mafodotin
- belinostat
- bendamustine
- benznidazole
- berotralstat
- bevacizumab
- bexarotene
- bleomycin
- blinatumomab
- boceprevir
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- bromfenac ophthalmic
- busulfan
- cabazitaxel
- cabozantinib
- capecitabine
- carbamazepine
- carboplatin
- carfilzomib
- carmustine
- ceritinib
- certolizumab
- chlorambucil
- chloramphenicol
- ciltacabtagene autoleucel
- cisplatin
- clarithromycin
- clofarabine
- clozapine
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- copanlisib
- crizotinib
- cyclosporine ophthalmic
- cytarabine
- dacarbazine
- dactinomycin
- dapsone
- daratumumab
- darunavir
- daunorubicin
- daunorubicin liposomal
- decitabine
- deferasirox
- delavirdine
- dexrazoxane
- diclofenac ophthalmic
- didanosine
- dinutuximab
- docetaxel
- doxorubicin
- doxorubicin liposomal
- duvelisib
- eflornithine
- elotuzumab
- elranatamab
- emtricitabine
- enfortumab vedotin
- entrectinib
- epcoritamab
- epirubicin
- eribulin
- erythromycin
- etanercept
- ethambutol
- ethotoin
- etoposide
- fam-trastuzumab deruxtecan
- fedratinib
- fexinidazole
- floxuridine
- fludarabine
- fluorouracil
- fluphenazine
- flurbiprofen ophthalmic
- fosamprenavir
- fosphenytoin
- fostamatinib
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- indinavir
- infliximab
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- ipilimumab
- irinotecan
- irinotecan liposomal
- isatuximab
- isoniazid
- itraconazole
- ixabepilone
- ixazomib
- lamivudine
- larotrectinib
- leflunomide
- lenalidomide
- levamisole
- levoketoconazole
- lifileucel
- linezolid
- lisocabtagene maraleucel
- lomustine
- lonafarnib
- loncastuximab tesirine
- lorlatinib
- lumateperone
- lurasidone
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- lymphocyte immune globulin, anti-thy (equine)
- mechlorethamine
- melphalan
- melphalan flufenamide
- mephenytoin
- mercaptopurine
- methotrexate
- mibefradil
- miconazole
- mitomycin
- mitotane
- mitoxantrone
- mogamulizumab
- momelotinib
- mosunetuzumab
- moxetumomab pasudotox
- obecabtagene autoleucel
- obinutuzumab
- ofatumumab
- olanzapine
- olaparib
- olaratumab
- omacetaxine
- oxaliplatin
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- paliperidone
- pazopanib
- pegaspargase
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- penicillamine
- pentostatin
- phenylbutazone
- phenytoin
- pirtobrutinib
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- posaconazole
- pralatrexate
- procainamide
- procarbazine
- promazine
- propylthiouracil
- revumenib
- ribociclib
- risperidone
- ritlecitinib
- ritonavir
- rituximab
- romidepsin
- ropeginterferon alfa-2b
- rucaparib
- ruxolitinib
- sacituzumab govitecan
- samarium sm 153 lexidronam
- saquinavir
- sarilumab
- satralizumab
- selinexor
- sirolimus
- sirolimus protein-bound
- smallpox vaccine
- sodium phosphate p32
- stavudine
- stiripentol
- streptozocin
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfisoxazole
- suprofen ophthalmic
- tafasitamab
- talazoparib
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- telaprevir
- telithromycin
- temozolomide
- teniposide
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- thioguanine
- thiotepa
- ticlopidine
- tisagenlecleucel
- tisotumab vedotin
- tocilizumab
- tofacitinib
- topotecan
- tositumomab
- trabectedin
- trastuzumab
- treosulfan
- trimetrexate
- troleandomycin
- tucatinib
- valganciclovir
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voriconazole
- vorinostat
- voxelotor
Chloramphenicol/hydrocortisone/polymyxin b ophthalmic disease interactions
There are 3 disease interactions with chloramphenicol / hydrocortisone / polymyxin b ophthalmic which include:
More about chloramphenicol / hydrocortisone / polymyxin b ophthalmic
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.